Transient transfection at large scale for clinical AAV9 vector manufacturing

被引：0
|
作者：
Legmann, R. [1 ]
机构：
[1] Pall Life Sci, Proc Dev, Westborough, MA USA
来源：
CYTOTHERAPY | 2020年 / 22卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
309
引用
收藏
页码：S151 / S151
页数：1
相关论文
共 50 条
  • [21] Design of an AAV9-Based Gene Therapy Vector Able to Evade Neutralization by a Novel, Potent α-AAV9 Neutralizing Antibody
    Giles, April R.
    Govindasamy, Lakshmanan
    Somanathan, Suryanarayan
    Wilson, James M.
    MOLECULAR THERAPY, 2017, 25 (05) : 338 - 338
  • [22] Targeting cost-effective large-scale manufacturing for r-AAV vectors by transient transfection using Pall's Allegro™ STR bioreactor
    Collignon, M. L.
    Pedregal, A.
    Mainwaring, D.
    Blondel, S.
    Mullan, B.
    Cariou, A.
    Rousseaux, C.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A81 - A81
  • [23] Broad Antibody Cross Reactions to Different AAV Serotypes in NHPs Following an Intravenous AAV9 or AAV1 Vector Delivery
    Pineda, Ricardo
    Meadows, Aaron
    Fu, Haiyan
    MOLECULAR THERAPY, 2018, 26 (05) : 106 - 106
  • [24] AAV9 vector encoding hGAA improves synaptic pathology of the neuromuscular junction in Pompe disease
    Falk, D. J.
    Todd, A. G.
    Soustek, M. S.
    Cloutier, D. C.
    ElMallah, M.
    Fuller, D. D.
    Byrne, B. J.
    NEUROMUSCULAR DISORDERS, 2013, 23 (9-10) : 829 - 829
  • [25] Development of Novel Lipoplex Formulation Methodologies to Improve Large Scale Transient Transfection for Lentiviral Vector Manufacture
    Williams, Thomas
    Knevelman, Carol
    Mitrophanous, Kyri
    Miskin, James E.
    Davies, Lee
    Rafiq, Qasim
    MOLECULAR THERAPY, 2023, 31 (04) : 751 - 751
  • [26] Intrathecal delivery of AAV9 vectors to model and rescue a large animal model of SMA
    Duque, S.
    Porensky, P.
    William, D. A.
    Odermatt, P.
    Nlend, R. Nlend
    Bevan, A. K.
    Foust, K.
    Braun, L.
    Schmelzer, L.
    Schumperli, D.
    Kaspar, B. K.
    Burghes, A. H. M.
    NEUROMUSCULAR DISORDERS, 2013, 23 (9-10) : 797 - 797
  • [27] Generation of retroviral vector for clinical studies using transient transfection
    Yang, SL
    Delgado, R
    King, SR
    Woffendin, C
    Barker, CS
    Yang, ZY
    Xu, L
    Nolan, GP
    Nabel, GJ
    HUMAN GENE THERAPY, 1999, 10 (01) : 123 - 132
  • [28] Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse
    Schuster, Daniel J.
    Dykstra, Jaclyn A.
    Riedl, Maureen S.
    Kitto, Kelley F.
    Belur, Lalitha R.
    McIvor, R. Scott
    Elde, Robert P.
    Fairbanks, Carolyn A.
    Vulchanova, Lucy
    FRONTIERS IN NEUROANATOMY, 2014, 8
  • [29] Stable and inducible AAV producer cell lines to support large scale AAV manufacturing
    Green, A. M.
    Parker, A.
    Oden, V.
    Zafrani, E.
    Kolaci, M.
    Finger-Baker, I.
    McCoy, J.
    Rodriguez-Lebron, E.
    Warrington, K.
    Todd, G.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A152 - A152
  • [30] Addressing Large-Scale Viral Vector Manufacturing Using an Optimized Pei- Based Transfection Process
    Kedinger, Valerie
    Nyamay'Antu, Alengo
    Porte, Mathieu
    Erbacher, Patrick
    MOLECULAR THERAPY, 2018, 26 (05) : 157 - 157
12345